MILAN, April 28, 2022 /PRNewswire/ -- Diadem SpA, a company developing the first blood-based test for the early prediction of progression to Alzheimer's disease (AD), today announced release of a new ...
Sequence specificity of docetaxel (Doc) and the proteasome inhibitor PS-341 combinations in androgen-independent (AI) prostate cancer (CaP) No significant financial relationships to disclose. This is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback